 |
 |
Neurosearchsays sees DKK 85 mln 99 loss
COPENHAGEN, June 29 (Reuters) - Danish pharmaceuticals firm
Neurosearch said on Tuesday it had agreed with Bristol-Myers Squibb
(NYSE:BMY - news) to cancel their agreement on the joint development of
Neurosearch"s anti-Parkinsons disease drug Brasofine. <snip>
http://biz.yahoo.com/rf/990629/dt.html
--
Judith Richards, London, Ontario, Canada
<[log in to unmask]>
^^^
\ /
\ | / Today’s Research
\\ | // ...Tomorrow’s Cure
\ | /
\|/
```````